Venture capital fund · 2 deals
Every published round Novo Ventures took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Loose Cannon | Series A | 11 Jan 2023 | $12m | Lead | SmartCompany, Startup Daily | |
| Spinifex Pharmaceuticals | Series C | 13 May 2014 | $45m | Participant | bionity.com, GBS Ventures (Tue 30 Jun 2015), clinicalleader.com, GBS Ventures (Tue 13 May 2014) |
Companies Novo Ventures has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Loose Cannon | 11 Jan 2023, Series A | 1 | 1 | |
| Spinifex Pharmaceuticals | 13 May 2014, Series C | 1 | 0 |
Fund closes reported for Novo Ventures, as distinct from the investments it has made.
Companies Novo Ventures has backed that another company then bought. An exit for the holding, not a deal Novo Ventures did.
| Company | Bought by | Kind | Announced | Price |
|---|---|---|---|---|
| Spinifex Pharmaceuticals | Novartis International | Acquisition | 29 Jun 2015 | $200m+ |
| Spinifex Pharmaceuticals | Novartis | Acquisition | 29 Jun 2015 | $700m |
Stories naming Novo Ventures. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Early-2023 roundup of startup raises: a solar software company closed a Series B, an adventure-tech firm landed Series A money, and an angel investing platform raised seed capital.
Milo radio maker Loose Cannon Systems has raised a A$12 million Series A led by De Novo Ventures with XT Ventures. Founder Peter Celinski previously sold Avega Systems to Altec Lansing and earlier crowdfunded US$2.5 million.
Also SmartCompany
GBS Ventures reports Novartis has agreed to acquire chronic-pain drug developer Spinifex Pharmaceuticals for US$200 million upfront plus milestones, recalling the company's 2005, 2008 and 2014 venture rounds and its Australian investors.
Also GBS Ventures·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·novartis.com·clinicalleader.com·Brandon Capital portfolio·Startup Daily·Startup Daily·Startup Daily·anthillonline.com·@AuManufacturing·materresearch.org.au·Business News Australia